Ao Zhang
State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.
Journal: Annals of neurology
Published: December 28, 2025
Whole-Exome Profiling of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma of the Nasopharynx.
Journal: Endocrine pathology
Published: October 22, 2025
IL-6 receptor blockade impedes proinflammatory atypical Treg subset associated with immune checkpoint inhibitor-induced inflammatory arthritis.
Journal: The Journal of clinical investigation
Published: September 24, 2025
AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation.
Journal: Signal transduction and targeted therapy
Published: April 22, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinoma.
Journal: The Journal of clinical investigation
Published: April 03, 2024
Thyroid function and associated mood changes after COVID-19 vaccines in patients with Hashimoto thyroiditis.
Journal: Frontiers in immunology
Published: December 22, 2022
Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis.
Journal: EClinicalMedicine
Published: November 24, 2022
Parent Acceptance toward Inactivated COVID-19 Vaccination in Children with Acute Lymphoblastic Leukemia: The Power of Oncologist and Alliance.
Journal: Vaccines
Published: October 25, 2022
Serial negative response after standard and third (Booster) dose of COVID-19 inactivated vaccine is associated with low vitamin D levels in patients with solid cancers.
Journal: Frontiers in medicine
Published: March 17, 2022
Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.
Journal: Cancer cell international
Published: November 25, 2021
Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.
Journal: Cancer cell international
Published: May 28, 2021
Last Updated: 09/26/2026